Ana Rebollo Rubio

435 total citations
18 papers, 352 citations indexed

About

Ana Rebollo Rubio is a scholar working on Nephrology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Ana Rebollo Rubio has authored 18 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 4 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Ana Rebollo Rubio's work include Dialysis and Renal Disease Management (6 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Multiple Sclerosis Research Studies (2 papers). Ana Rebollo Rubio is often cited by papers focused on Dialysis and Renal Disease Management (6 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Multiple Sclerosis Research Studies (2 papers). Ana Rebollo Rubio collaborates with scholars based in Spain, United States and Germany. Ana Rebollo Rubio's co-authors include José Miguel Morales‐Asencio, Miguel Fernández‐Arquero, Emilio G. de la Concha, Patricia Vigil, Isabel Polanco, M. Á. Figueredo, Roberto Alcázar Arroyo, Carlos Maluenda, Laura Conejero and Alfonso Martı́n and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Medicine & Science in Sports & Exercise.

In The Last Decade

Ana Rebollo Rubio

16 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Rebollo Rubio Spain 8 117 79 70 55 52 18 352
Y. St. Pierre Canada 9 72 0.6× 14 0.2× 14 0.2× 56 1.0× 12 0.2× 22 376
Sema Yılmaz Türkiye 10 31 0.3× 38 0.5× 32 0.5× 20 0.4× 7 0.1× 57 319
Joep Welling Netherlands 10 47 0.4× 20 0.3× 41 0.6× 95 1.7× 5 0.1× 18 365
Kun Xiang China 8 25 0.2× 10 0.1× 33 0.5× 20 0.4× 17 0.3× 19 361
Miriam Kimel United States 14 145 1.2× 29 0.4× 55 0.8× 50 0.9× 2 0.0× 32 556
Kunihiko Yoshiya Japan 12 34 0.3× 293 3.7× 26 0.4× 39 0.7× 6 0.1× 27 483
Nisha Nigil Haroon Canada 11 146 1.2× 8 0.1× 82 1.2× 81 1.5× 7 0.1× 18 657
Nedim Yılmaz Selçuk Türkiye 9 38 0.3× 115 1.5× 45 0.6× 12 0.2× 3 0.1× 23 287
Dany Matar United States 8 79 0.7× 197 2.5× 19 0.3× 35 0.6× 3 0.1× 11 306
Selvihan Beysel Türkiye 13 13 0.1× 97 1.2× 62 0.9× 99 1.8× 9 0.2× 38 491

Countries citing papers authored by Ana Rebollo Rubio

Since Specialization
Citations

This map shows the geographic impact of Ana Rebollo Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Rebollo Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Rebollo Rubio more than expected).

Fields of papers citing papers by Ana Rebollo Rubio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Rebollo Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Rebollo Rubio. The network helps show where Ana Rebollo Rubio may publish in the future.

Co-authorship network of co-authors of Ana Rebollo Rubio

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Rebollo Rubio. A scholar is included among the top collaborators of Ana Rebollo Rubio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Rebollo Rubio. Ana Rebollo Rubio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Rubio, Ana Rebollo, et al.. (2025). Challenges in the diagnosis and follow-up of Cushing’s syndrome: Evaluating LC-MS/MS as a confirmation method for urinary free cortisol analyses. Clinica Chimica Acta. 568. 120129–120129. 1 indexed citations
2.
Rubio, Ana Rebollo, et al.. (2017). Biomarkers associated with mortality in patients undergoing dialysis. Journal of Renal Care. 43(3). 163–174. 5 indexed citations
3.
Rubio, Ana Rebollo, et al.. (2017). Depression, anxiety and health‐related quality of life amongst patients who are starting dialysis treatment. Journal of Renal Care. 43(2). 73–82. 49 indexed citations
4.
Rubio, Ana Rebollo, et al.. (2017). Utilidad del índice de masa corporal en pacientes con enfermedad renal crónica. Enfermería Nefrológica. 20(4). 316–322. 3 indexed citations
5.
Rubio, Ana Rebollo, et al.. (2016). Adherencia Terapéutica relacionada con el Estatus Nutricional de unacohorte de pacientes en Tratamiento Renal Sustitutivo con Hemodiálisis. Enfermería Nefrológica. 19(1). 56–56.
6.
Rubio, Ana Rebollo, et al.. (2016). Fragilidad: ¿Cómo podemos detectarla?. Enfermería Nefrológica. 19(2). 170–173. 3 indexed citations
7.
Rubio, Ana Rebollo, et al.. (2015). Review of studies on health related quality of life in patients with advanced chronic kidney disease in Spain.. PubMed. 35(1). 92–109. 51 indexed citations
8.
Rubio, Ana Rebollo, et al.. (2015). Valoración de la acogida de pacientes que inician terapia renal sustitutiva: Nivel de satisfacción. Enfermería Nefrológica. 18(2). 97–102. 3 indexed citations
9.
Rubio, Ana Rebollo, et al.. (2014). Grado de Discapacidad en Personas que Inician Terapia Sustitutiva Renal. SHILAP Revista de lepidopterología.
10.
Rubio, Ana Rebollo, et al.. (2014). Influencia de la consulta de enfermería de enfermedad renal crónica avanzada en pacientes que inician tratamiento renal sustitutivo. Enfermería Nefrológica. 17(4). 243–250. 5 indexed citations
11.
Kilpatrick, Marcus W., et al.. (2014). Affective And Enjoyment Responses To High-intensity Interval Training In Overweight And Sedentary Individuals. Medicine & Science in Sports & Exercise. 46. 212–212. 1 indexed citations
13.
Herrera, J., Roxana Cobo, M. Fernández, et al.. (2011). Análisis de efectividad del citrato de fentanilo sublingual en pacientes con dolor irruptivo: estudio Sublime. Dialnet (Universidad de la Rioja). 18(4). 207–218. 4 indexed citations
14.
Rubio, Ana Rebollo, et al.. (2002). Interleukin-10 polymorphisms in Spanish Multiple Sclerosis patients. Journal of Neuroimmunology. 131(1-2). 168–172. 29 indexed citations
15.
Martı́n, Alfonso, Miguel Fernández‐Arquero, Alejandro Balsa, et al.. (2001). Primary association of a MICA allele with protection against rheumatoid arthritis. Arthritis & Rheumatism. 44(6). 1261–1265. 43 indexed citations
16.
Concha, Emilio G. de la, Miguel Fernández‐Arquero, Patricia Vigil, et al.. (2000). Celiac disease and TNF promoter polymorphisms. Human Immunology. 61(5). 513–517. 65 indexed citations
17.
Fernández‐Arquero, Miguel, Roberto Alcázar Arroyo, Ana Rebollo Rubio, et al.. (1999). Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology. 53(6). 1361–1361. 63 indexed citations
18.
Golik, Ahuva, et al.. (1991). Elevated serum liver enzymes in obesity: a dilemma during clinical trials.. PubMed. 15(12). 797–801. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026